Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline – Xconomy
Xconomy |
Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline
Xconomy Avrobio has had encouraging early results testing its experimental gene therapy to treat Fabry disease, an inherited enzyme deficiency that leads to a dangerous fatty buildup in the body. As the biotech startup gears up for more tests, it now has $60 … AVROBIO, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for Lysosomal Storage … With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline Chasing Genzyme, AvroBio bags $60M to fund Fabry disease gene therapy trial |
